Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects.
about
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersDual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell modelCombination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cellsKnocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells.Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate.The Unforeseen Non-Coding RNAs in Head and Neck Cancer.
P2860
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@en
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@nl
type
label
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@en
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@nl
prefLabel
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@en
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@nl
P2093
P2860
P356
P1476
Combining the chemotherapeutic ...... ynergic pro-apoptotic effects.
@en
P2093
Alexandru Irimie
Cornelia Braicu
Ioana Berindan-Neagoe
P2860
P304
P356
10.2147/IJN.S36523
P407
P577
2012-12-12T00:00:00Z